News
-
Preliminary results of an early intervention clinical study of amantadine in patients with SARS-COV-2 infection
-
Results from clinical trials on the efficacy of amantadine in the treatment of COVID-19
Amantadine is ineffective in the treatment of COVID-19 – initial clinical studies have shown. No difference to placebo was observed in inpatient patients. The study of the medicine was conducted under the supervision of Prof. Adam Barczyk of the Silesian Medical University.
-
Results of the call Creation and Development of the Oncological Clinical Research Support Centres
-
Ceremonial opening of the Clinical Research Development Centre in Military Institute of Medicine
On 27 January of this year, we officially opened the activities of the Center for Clinical Research – a new cell of the Military Institute of Medicine dedicated to the realization of commercial and non-commercial clinical studies, founded as part of a project funded by the Medical Research Agency.
-
TheMedical Research Agency is launching a call for non-commercial clinical trials (ABM/2022/1).
-
Scientists at Białystok Medical University have identified a genetic variant that more than doubles the risk of severe progression and death from COVID-19
-
Medical Research Agency has concluded a cooperation agreement with the Polish Hospital Association
The President of the Agency for Medical Research, MD, PhD Radosław Sierpiński, has signed the cooperation agreement with the President of the Polish Hospital Association (PFSz), Prof. Jarosław J. Fedorowski.
-
Results of the call for the development of innovative therapeutic solutions based on RNA technology
-
Medical Research Agency summarized activities and announced plans for 2022
-
President of MRA signed an agreement to implement the first projects within the competition for non-commercial research in psychiatry and neurology
The President of the Medical Research Agency has signed the first agreement in the framework of the call in the field of psychiatry and neurology for the implementation of non-commercial clinical traials with the Institute of Psychiatry and Neurology . 10 projects with a total value of over 87 million PLN have been recommended for funding.